OFEGE PHARM LTD

Company limited by guarantee

Company Registration Number:
09689398 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2024

Period of accounts

Start date: 01 August 2023

End date: 31 July 2024

OFEGE PHARM LTD

Company limited by guarantee

Contents of the Financial Statements

for the Period Ended 31 July 2024

Company Information - 3
Report of the Directors - 4
Income and Expenditure Account - 5
Balance sheet - 6
Additional notes - 8

OFEGE PHARM LTD

Company limited by guarantee

Company Information

for the Period Ended 31 July 2024




Director: Edith Ofege
None
Secretary: None
Registered office: 10
Edgefield Close
Redditch
England
B98 7WB
Company Registration Number: 09689398 (England and Wales)

OFEGE PHARM LTD

Company limited by guarantee

Directors' Report Period Ended 31 July 2024

The directors present their report with the financial statements of the company for the period ended 31 July 2024

Principal Activities

Provision of Healthcare and Pharmaceutical Services.

Directors

The directors shown below have held office during the whole of the period from 01 August 2023 to 31 July 2024
Edith Ofege
None

Secretary
None

This report was approved by the board of directors on 27 April 2025
And Signed On Behalf Of The Board By:

Name: Edith Ofege
Status: Director

OFEGE PHARM LTD

Company limited by guarantee

Income and Expenditure Account

for the Period Ended 31 July 2024


Notes

2024
£

2023
£
Turnover 37,047 -
Gross surplus or (deficit) 37,047 -
Administrative Expenses ( 19,660 ) -
Operating surplus or (deficit) 17,387 -
Interest Payable and Similar Charges ( 200 ) -
Surplus or (deficit) before tax 17,187 -
Surplus or (deficit) for the period 17,187 -

The notes form part of these financial statements

OFEGE PHARM LTD

Company limited by guarantee

Balance sheet

As at 31 July 2024


Notes

2024
£

2023
£
Fixed assets
Total fixed assets: - -
Current assets
Total net assets (liabilities): - -

The notes form part of these financial statements

OFEGE PHARM LTD

Company limited by guarantee

Balance sheet continued

As at 31 July 2024


Notes

2024
£

2023
£
Reserves

For the year ending 31 July 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 27 April 2025
And Signed On Behalf Of The Board By:

Name: Edith Ofege
Status: Director

The notes form part of these financial statements

OFEGE PHARM LTD

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

OFEGE PHARM LTD

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 0 0

OFEGE PHARM LTD

Company limited by guarantee

Notes to the Financial Statements

for the Period Ended 31 July 2024

  • 3. Off balance sheet disclosure

    No